Pertuzumab - Genentech/Roche
At a glance
- Drug Originator Genentech; Roche
- Drug Licenced by Chugai Pharmaceutical
- Drug Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Dimerisation inhibitors
- USA Patent Applicants GENENTECH
- USA Patents 304
- BLAs 1
- International Patents 3,161

Disclaimer